John M. Holliman III, Executive Chairman at Capstone Therapeutics Corp. (CAPS), bought 150,000 shares at $0.14 ($21K) on 2012-10-19, disclosed to the SEC on 2012-10-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.14 | 100,000 | $14K | 66.7% |
| 2 | $0.14 | 50,000 | $7K | 33.3% |
| Total | $0.14 avg | 150,000 | $21K | 100% |
| Filing → |
| CAPS | BUY | 2008-12-18 | $5K | — | Filing → |
| OLGC | BUY | 2008-08-19 | $17K | — | Filing → |
| OLGC | BUY | 2008-03-13 | $18K | — | Filing → |